Enhanced anti-proliferative action of busulphan by quercetin on the human leukaemia cell line K562.
Hoffman
R
R
Cancer Research Campaign Laboratories, Department of Medical Oncology, Charing Cross Hospital, London, UK.
Graham
L
L
Newlands
E S
ES
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002066:Busulfan / Q000008:administration & dosage; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D004357:Drug Synergism; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000473:pathology; D011794:Quercetin / Q000008:administration & dosage; D014407:Tumor Cells, Cultured / Q000187:drug effects
D011794:Quercetin; D002066:Busulfan